The major aim of this work was to study the protective effects of the cysteinyl-leukotriene antagonist montelukast (ML) and L-Carnitine (LC) against cyclophosphamide (CP)-induced pulmonary injury in experimental rats. Thirty adult male albino rats were categorized at random into five groups of 6 rats each. The first group served as normal control group. All other groups were injected once with CP (150 mg/kg, i.p.). The second group was kept as CP toxicity control group The third group was injected with ML (10 mg/kg/day, i. 
Introduction
The alkylating agent cyclophosphamide (CP) is a very popular cytotoxic drug used in most cancer chemotherapy and immunosuppressive protocols. Its neoplastic activity is evident against different types of human malignancies Oxidative stress and reactive oxygen species (ROS) generation caused by CP exposure can negatively modify the components of both healthy and neoplastic cells. Lack of detoxifying enzymes in the lungs is a cause of selective CP toxicity to lung tissue. CP is well known to cause various histopathological patterns of lung injury, including diffuse interstitial and alveolar edema as well as inflammatory changes that progress to lung fibrosis in both animals and humans. Lung toxicity by CP is probably induced directly on pulmonary tissue or indirectly via pulmonary inflammatory cell activation 3 Properly, protective agents should be considered to alleviate severe tissue injury caused by antineoplastic agents like CP, but considering not to interfere with their beneficial anticancer effect. Montelukast (ML) is abronchodilator anti-inflammatory drug used in management of bronchial asthma. It is a selective antagonist on cysteinylleucotriene receptor thus reducing eosinophilic inflammation of the airway 6 . The non-protein amino acid L-carnitine (LC; β-hydroxy-γ-trimethyl-amino-butyric acid) is synthesized from the essential amino acids lysine and methionine. It participates in the metabolism of branched chain amino acids, beta oxidation of fatty acids, and cell membrane stabilization. LC was reported by many in vitro and animal studies to have free radical scavenging potential scavenger, thus protecting antioxidant enzymes from oxidative damage 7 . It also has proved to possess anti-inflammatory activity 8 .
This study was designed to examine the possible protective effect of ML, LC and their combinations against CP-induced lung injury in experimental rats. The protective effects of these drugs were evaluated by assessment of lung tissue glutathione reduced (GSH), thiobarbituric acid reactive substances (TBARS), catalase (CAT), glutathione-S-transferase (GST), superoxide dismutase (SOD), and nitrite (NO2 -) contents as oxidative and nitrosative stress biomarkers, in addition to serum levels of cyclooxygenase-II (COX-II) and lipooxygenase (LOX) as inflammatory parameters.
Materials and method

Animals
Adult male albino rats weighing 180-200 g were procured from 
Experimental design
Thirty adult male albino rats were categorized at random into five groups of 6 rats each. The first group received only vehicles and served as normal control group. All other groups were injected once with CP (150 mg/kg, i.p.), where the second group was kept as toxicity control group and received vehicles of drugs only. The third group was injected with ML (10 mg/kg/day, i.p.) once daily for 10 consecutive days before CP injection. The fourth group received LC (250 mg/kg/day, i.p.) once daily for 10 consecutive days before CP injection. The fifth group received ML plus LC once daily for 10 consecutive days before CP injection.
Twenty-four hours after the last dose of the specific treatment, rats were anesthetized with light ether and blood samples withdrawn directly from heart for preparation of serum. Serum was separated following centrifugation (Beckman GS-6 centrifuge, USA) at 4000 rpm for 10 minutes at 4˚C and stored at -20˚C prior to analysis. Soon, rats were opened then lungs were removed, washed three times in ice-cooled saline, blotted individually on ash-free filter paper and used for preparation of tissue homogenates.
Chemicals
Cyclophosphamide 
Preparation of lung tissue homogenate
Tissue homogenates (10% w/v) were prepared in ice-cooled 
Biochemical estimations
Estimation of oxidative stress parameters
Glutathione reduced (GSH) content was measured using the method of Beuter
9
. Lipid peroxidation was estimated as TBARS according to the method described by Mihara and Uchiyama 10 . Antioxidant enzymes CAT, SOD and GST were estimated by the methods of 
Estimation of inflammatory mediators
Inflammatory enzymes including COX-II and LOX were assayed using ELISA kit, obtained from Glory Science Company (St, Del Rio, USA) according to the method of Van Weemen and Schuurs
15
.
Histophathological examination
Autopsy samples were taken from lung of rats in different groups and fixed in 10% formalin solution in saline for twenty four hours.
Samples were washed with distilled water followed by dehydration using serial dilutions of alcohol. Xylene was used to dehydrate specimens, which were then embedded in paraffin for 24 hours in a hot air oven at 56 ºC. Tissue blocks 4 μ thick were prepared by slidge microtome using paraffin bees wax, then slides were deparaffinized and stained by hematoxylin and eosin as described by Banchroft and Steven
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Statistical analysis
Results are presented as mean ± SEM. All the statistical analyses were performed using one way analysis of variance (ANOVA) test with turkey's post hoc comparison test applied across all groups.
Significance was based on p value < 0.05. Data analysis was accomplished using the computer software program statistical package for the social sciences (SPSS, version 20).
Results
Mean lung GSH level showed significant decrease in rats treated with CP as compared with normal control rats. Pretreatment with ML, LC or ML plus LC showed significant increases in lung GSH levels in comparison to CP control group. Alternatively, lung TBARS and NO2 -significantly increased in rats treated with CP as compared with normal control group. Protection with ML, LC or ML plus LC significantly corrected the three parameters as compared to CPtreated rats. Combined effect of ML and LC was significantly better than either drug effect alone regarding both GSH, TBARS and NO2 -.
In addition, the activities of lung GST and SOD were decreased in CP control group as compared to normal control group.
Administration of ML, LC or ML plus LC resulted in marked increases
in tissue activities of GST and SOD as compared to CP-treated group. Alternatively, activity of lung CAT in CP rats showed no significant alteration as compared to normal control group (Table 1) .
Serum levels of LOX and COX-II were significantly increased in rats treated with CP as compared with normal control rats. Pretreatment with ML, LC or ML plus LC showed significant decreases in serum levels of COX-II and LOX as compared to CP-treated group.
Combination of ML and LC resulted in significantly lower levels of serum COX-II and LOX as compared to either drug alone (Table 2) .
Histopathological examination of CP-treated rats showed hyperplasia of bronchioles with prebronchiolar leukocytic inflammatory cell infiltration. Alternatively, pretreatment with ML, LC or ML plus LC showed notable protection regarding histopathological lesions, returninig to more or less normal architecture except for mild emphysema ( Fig. 1-5 ).
Discussion
Most currently used anticancer chemotherapeutic agents like CP adversely affect normal cells, which may seriously affect patients' quality of life, regardless of their great curative effects 17 . Therefore, there is a necessity to develop adjuvant therapy which may be used in conjunction with cancer chemotherapy to improve the efficacy of the treatment or reduce the associated undesirable side effects.
In the present study, CP is concerned due to its wide popularity as Inflammatory pathway is also involved in the pathogenesis of experimental alkylating agent-induced toxicity 22 . Regarding inflammatory progression, several mediators may arise from the COX-II cascade involving release of biologically active prostaglandins (PG's), or may be synthesized through the action of LOX, involving leukotrienes (LT's) which are the second main family of arachidonic acid derivatives, which also have a major role in the inflammatory process. Previous investigators reported the key roles of COX and LOX pathways in the pathogenesis as well as in the protective strategies of lung injury 23, 24 . In harmony with these reports, CP-treated animals in the present investigation showed significantly elevated levels of serum COX-II and LOX levels in comparison with normal control animals ( Table 2) .
Results of the present investigation clearly show antioxidant potentials for ML and LC, alone or in combination, regarding their effect on GSH, TBARS, GST, SOD and NO2 -levels. It seems that LC is a more potent antioxidant agent compared to ML, which is apparent from the significant difference between LC and ML regarding all measured oxidative parameters in the direction of LC being better (Table 1 ). In agreement, it was reported that LC might be a good antioxidant through different mechanisms. First, LC can act as a direct free radical scavenger. Second, it is an essential factor for synthesis of adenosine triphosphate (ATP) through mitochondrial fatty acid mobilization and oxidation. At this step of ATP synthesis, a large amount of oxygen is consumed, and the oxygen is reduced to water at the end of the TCA cycle. Then, oxygen concentration decreases and ROS formation is also reduced.
Third, LC also might interfere with the ROS formation through chelation of ferrous ion which is a catalyst in free radical generation reactions like Fenton and Haber-Weiss reactions. Finally, LC antioxidant power may be due to its ability to increase activities of antioxidant enzymes like SOD and others 7, 8, 25 . Regarding ML, it was reported to correct lipopolysaccharide (LPS)-induced elevations in TBARS and depletion in GSH in a lung model of injury 26 . On the other side, investigation of anti-inflammatory potential of ML and LC in the current investigation revealed true anti-inflammatory ability of both agents represented by significant reductions of COX-II and LOX levels in sera of ML or LC-pretreated rats compared with control CP rats ( Table 2) . Anti-inflammatory effects of the two test Opposite to results of oxidative parameters, ML showed more significant anti-inflammatory potential compared with LC. This is in harmony with recent investigations declaring potent antiinflammatory potential for ML 28, 29 . Besides the well-known inhibitory Fortunately, the present study results showed that combination of ML with LC showed more significant protective effect than either drug alone regarding levels of tissue GSH, TBARS, GST, SOD and NO2 -, and levels of serum COX-II and LOX. It seems that combination has the benefits of potent anti-oxidant effect of LC and potent antiinflammatory effect of ML. Results of the present study strongly suggest that ML and LC are good agents to protect against CP-induced lung damage, particularly through their anti-oxidant (LC is stronger) and anti-inflammatory (ML is stronger) potentials. This is promising for further clinical trials involving application of ML and LC pretreatments before CP chemotherapeutic intervention to decrease its hazardous effect on lung and probably other tissues.
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